James G. Hall's most recent trade in Lifecore Biomedical Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on June 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | James G. Hall | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 150,000 | 201,096 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | James G. Hall | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 75,000 | 276,096 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | James G. Hall | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 150,000 | 150,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | James G. Hall | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 45,000 | 45,000 | - | - | Right to Buy Restricted Stock Unit (RSU) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 10,000 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 10.42 per share. | 05 Aug 2022 | 10,000 | 54,156 (0%) | 0% | 10.4 | 104,200 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 05 Aug 2022 | 3,060 | 51,096 (0%) | 0% | 0 | Common Stock | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 49,755 | 49,755 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 10,245 | 10,245 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 66,763 | 66,763 | - | - | Non-Qualified StockOption (right to buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 8,237 | 8,237 | - | - | Incentive Stock Option (right to buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 5,625 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.82 per share. | 23 Jul 2021 | 5,625 | 46,721 (0%) | 0% | 11.8 | 66,488 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 3,574 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.82 per share. | 23 Jul 2021 | 3,574 | 42,725 (0%) | 0% | 11.8 | 42,245 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share. | 23 Jul 2021 | 2,565 | 44,156 (0%) | 0% | 11.8 | 30,318 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.82 per share. | 23 Jul 2021 | 1,629 | 41,096 (0%) | 0% | 11.8 | 19,255 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Purchase of securities on an exchange or from another person at price $ 10.62 per share. | 14 Apr 2021 | 10,000 | 39,151 (0%) | 0% | 10.6 | 106,200 | Common Stock |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 44,864 | 44,864 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 7,636 | 7,636 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | James G. Hall | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 3,574 | 3,574 | - | - | Right to Buy Restricted Stock Unit (RSU) |